NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.

Proceedings of the National Academy of Sciences of the United States of America2001Fiorucci S, Antonelli E, Morelli O, et al.

Study designOther primary literature

SubjectAnimal

Record checks

Study design: Other primary literature
Subject: Animal
Publication year: 2001
Source: doi.org
Abstract display: Not reproduced here
Publication status: Expression of concern
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Flagged

How to read this record →

Publication-status notice

Publication status: Expression of concern

Europe PMC relationship metadata: expression_of_concern_for.

View status evidence →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsCarbon TetrachlorideCollagenHypertension, PortalLiverLiver CirrhosisMaleNitratesNitric OxideNitric Oxide DonorsRatsRats, WistarSalicylatesUrsodeoxycholic Acid

DOI 10.1073/pnas.151136298

PMID 11447266

View source →